On Pre-emption, OTC Rule Among Signs Tipping Obama Administration’s Hand
This article was originally published in The Tan Sheet
Executive Summary
FDA has not altered its support of pre-emption in product liability suits but there are signs it will happen under the Obama administration
You may also be interested in...
In Brief
FDA clarifies pre-emption on OTC labeling
Pharma Outside the Fray As Obama Re-Evaluates Bush’s Pre-emption Policy
The good news for drug firms about President Obama's memo curtailing federal pre-emption state laws: It will not have any real impact on industry. The bad news: It will not matter because pre-emption in the drug arena already took a body blow in the Supreme Court's Wyeth v. Levine ruling
FDA Expands Acetaminophen, NSAID Labeling Beyond Tentative Final Rule
FDA's final rule for OTC products containing acetaminophen or nonsteroidal anti-inflammatory drugs requires warnings and revisions that go beyond changes the agency proposed in a 2006 tentative final rule